Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by CMHarring218431on Sep 20, 2024 3:08pm
126 Views
Post# 36233715

RE:RE:Analyst ratings

RE:RE:Analyst ratingsWhy did these goofballs even get into this 3-5 year stuff. You publish impressive clinical  results and then tell the world it won"t mean shite for another five years. It is probably the truth with this management but they can't last that long. Couldn't Look have presented a more positive outLOOK for the short term. Not asking that he sling it. Just provide confidence in the future like we have come a long way and we are preparing for the next step and reiterate how important these numbers are.Also, somebody tell him this is a public company and they damn well better be courting BP for shareholders benefit!!!
<< Previous
Bullboard Posts
Next >>